Testing a training tool for hospice clinicians caring for dementia patients
Official title: Study 3. Pilot Testing Feasibility, Acceptability, and Preliminary Efficacy of a Dementia-Enhanced Training and Tool for Home Hospice Clinicians in a Clinical Setting.
Run by Rutgers, The State University of New Jersey · NCT05719077 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new training program for hospice workers to see if it helps them better care for dementia patients and supports their families.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 90 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Trial ID | NCT05719077 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include family caregivers of individuals living with dementia who are enrolled in home hospice care and identify as either Black or White.
✕Probably not a fit
Patients who do not identify as Black or White or are not enrolled in home hospice care may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to evaluate the feasibility, acceptability, and preliminary efficacy of a dementia-enhanced training program and tool designed for home hospice clinicians. The study will involve 40 clinicians and 160 family caregivers, comparing those who receive the training to those who do not. Primary outcomes include caregiver burden reduction, while secondary outcomes focus on clinician knowledge and confidence regarding dementia care. The study will also explore the impact on family caregiver preparedness and patient discharge rates.
Why it matters
Potential benefit: If successful, this study could significantly reduce caregiver burden and improve the quality of care for patients with dementia in home hospice settings.
How similar studies have gone: Other studies have shown success in enhancing caregiver training and support, indicating potential for positive outcomes in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals are not excluded from this study based on gender. * Based on proportion of hospice workforce and family caregivers that are female, we expect 70%-80% of participants will be female. * Nurse, social worker, or family member who provides care to persons(s) living with dementia enrolled in home hospice care. * 19-90 years old. * Can complete data collection in English. * Family Caregivers: identify as White or Black/African American. Exclusion Criteria: * Participant is less than 19 years old or older than 90 years old. * Does not provide care to person(s) living with dementia enrolled in home hospice. * Cannot complete data collection in English. * Family Caregiver does not identify as White or Black/African American.
Where it's running
-
Rutgers Univeristy
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Elizabeth Luth, PhD — Rutgers University
- Study coordinator: Elizabeth Luth, PhD
- Email: eal133@ifh.rutgers.edu
- Phone: 646-512-0670
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Training hospice staff to collect sexual orientation and gender identity information
This study is testing a training program for hospice staff to help them better understand and support older LGBTQ+ patients with Alzheimer's and related conditions by collecting important information about their sexual orientation and gender identity.
-
ctDNA-guided stopping of immune therapy in advanced melanoma
This study tests whether stopping immune checkpoint inhibitor therapy after 12 months is safe for patients with advanced melanoma who have undetectable ctDNA and disease control.
-
Personalized brain-targeted TMS for smoking cessation
A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.
-
Luminal Bladder Cancer: Testing Neoadjuvant Therapy vs Immediate Surgery in Luminal MIBC
We’re testing whether moving straight to radical cystectomy is safe and effective for patients with luminal muscle-invasive bladder cancer compared to the standard neoadjuvant therapy followed by surgery.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Sun Safe Together: a digital skin cancer prevention approach for teens and their parents
A small, single-arm trial will test whether a 12-week digital program using teen MMS messages and a private Facebook group for parents can feasibly and acceptably improve sun safety among adolescents and their parents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.